Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concept-based learning of personalized prescribing.
Rissmann R, Dubois EA, Franson KL, Cohen AF. Rissmann R, et al. Br J Clin Pharmacol. 2012 Oct;74(4):589-96. doi: 10.1111/j.1365-2125.2012.04270.x. Br J Clin Pharmacol. 2012. PMID: 22420749 Free PMC article. Review.
Lomitapide.
Goulooze SC, Cohen AF, Rissmann R. Goulooze SC, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2015 Aug;80(2):179-81. doi: 10.1111/bcp.12612. Epub 2015 Jul 2. Br J Clin Pharmacol. 2015. PMID: 25702706 Free PMC article. No abstract available.
Bedaquiline.
Goulooze SC, Cohen AF, Rissmann R. Goulooze SC, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2015 Aug;80(2):182-4. doi: 10.1111/bcp.12613. Epub 2015 Jul 2. Br J Clin Pharmacol. 2015. PMID: 25702772 Free PMC article. No abstract available.
Mirabegron.
Goulooze SC, Cohen AF, Rissmann R. Goulooze SC, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2015 Oct;80(4):762-4. doi: 10.1111/bcp.12647. Epub 2015 Jun 5. Br J Clin Pharmacol. 2015. PMID: 25819590 Free PMC article.
Vemurafenib/dabrafenib and trametinib.
Rissmann R, Hessel MH, Cohen AF. Rissmann R, et al. Br J Clin Pharmacol. 2015 Oct;80(4):765-7. doi: 10.1111/bcp.12651. Epub 2015 Jun 11. Br J Clin Pharmacol. 2015. PMID: 25847075 Free PMC article. No abstract available.
Olaparib.
Goulooze SC, Cohen AF, Rissmann R. Goulooze SC, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2016 Jan;81(1):171-3. doi: 10.1111/bcp.12761. Epub 2015 Oct 24. Br J Clin Pharmacol. 2016. PMID: 26344419 Free PMC article.
Injection site reactions after subcutaneous oligonucleotide therapy.
van Meer L, Moerland M, Gallagher J, van Doorn MB, Prens EP, Cohen AF, Rissmann R, Burggraaf J. van Meer L, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2016 Aug;82(2):340-51. doi: 10.1111/bcp.12961. Epub 2016 May 31. Br J Clin Pharmacol. 2016. PMID: 27061947 Free PMC article. Review.
Sofosbuvir and daclatasvir.
Hessel MH, Cohen AF, Rissmann R. Hessel MH, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2016 Sep;82(3):878-9. doi: 10.1111/bcp.13011. Epub 2016 Jun 12. Br J Clin Pharmacol. 2016. PMID: 27198488 Free PMC article. No abstract available.
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.
Balak DM, van Doorn MB, Arbeit RD, Rijneveld R, Klaassen E, Sullivan T, Brevard J, Thio HB, Prens EP, Burggraaf J, Rissmann R. Balak DM, et al. Among authors: rissmann r. Clin Immunol. 2017 Jan;174:63-72. doi: 10.1016/j.clim.2016.09.015. Epub 2016 Nov 20. Clin Immunol. 2017. PMID: 27876460 Clinical Trial.
88 results